Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge.
Wong TY, Lee KS, Russ BP, Horspool AM, Kang J, Winters MT, Allison Wolf M, Rader NA, Miller OA, Shiflett M, Izac J, Varisco D, Sen-Kilic E, Cunningham C, Cooper M, Cyphert HA, Barbier M, Martinez I, Bevere JR, Ernst RK, Damron FH.
Wong TY, et al. Among authors: horspool am.
NPJ Vaccines. 2022 Mar 14;7(1):36. doi: 10.1038/s41541-022-00451-7.
NPJ Vaccines. 2022.
PMID: 35288576
Free PMC article.